MedPath

Patient Controlled Administration of Liquid Acetaminophen

Phase 1
Recruiting
Conditions
Pain
Pain, Postoperative
Interventions
Registration Number
NCT06498713
Lead Sponsor
Yale University
Brief Summary

This is a proof of concept pilot study investigating the feasibility and acceptability of patient controlled oral medication administration, using the commonly used and low risk medication in the hospital, oral acetaminophen.

Detailed Description

The primary objective of this prospective pilot study is to determine the feasibility of patient-controlled administration of liquid oral acetaminophen using recruitment rate and adherence to the study protocol rate as surrogate markers. Investigators hypothesize that patients will accept the new concept of self-controlled oral administration of liquid acetaminophen, with more than 50% patient enrollment rate and less than 20% withdrawal rate from the study group to the traditional nurse-administered acetaminophen pills.

The secondary objective of this study is to determine the preliminary efficacy of patient-controlled delivery of oral acetaminophen administration.

If the medication is spilled or otherwise not dispensed correctly, the patients will be instructed to report this instantly to the nurse. The nurse will document and provide a replacement.

All study participants have the option to call the nurse for assistance with break through pain. In addition, there is a call button to call for help with any other needs or discomfort.

All other medications, such as NSAIDs or oral opioids, will be administered as prescribed.

Participants will have to fill out a paper questionnaire and keep a pain diary, and nurses will have to fill out a questionnaire.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria

Participants

  • Adult patients older than 18 years old admitted to SRC for total shoulder and reverse total shoulder arthroplasty

Nurses

  • The nurse who will administer acetaminophen to a study patient.
Read More
Exclusion Criteria

Participants

  • Pregnant patient
  • Patients that cannot swallow pills or cannot take liquid (for example due to risk of aspiration)
  • Emergency surgery
  • Chronic pain
  • On home opioids, any other pain modulating medications including benzodiazepine, Neurontin, ketamine.
  • Past medical or social history of substance abuse disorder, including ethanol misuse disorder, marijuana misuse disorder
  • History of any psychiatric disorders including anxiety, depression, any cognitive dysfunction
  • Any patients who cannot provide informed consents on their own (those who would need Legally Authorized Representatives (LARs) or surrogates)
  • Liver dysfunction limiting amount of safe oral acetaminophen
  • baseline hyperbilirubinemia (ex: chronic liver disease, Gilbert's)
  • patients unable to take PO
  • Patients with neurologic, neuromuscular, or movement disorders unable to drink from a cup.

Nurses

  • any nurse who is not involved in the direct care of a study patient, or who is not comfortable with setting up the PCA pump.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nurse Administered AcetaminophenAcetaminophen 650 mg Oral TabletParticipants will receive acetaminophen pills 650 mg every 4 hours as needed (PRN) administered by nurse per standard of care
CADD pump Administered Acetaminophen (Participant Controlled)Acetaminophen 650mg LiquidParticipants will receive a CADD pump primed and programmed to deliver 650 mg liquid acetaminophen into a medication cup every 4 hours as needed (PRN).
CADD pump Administered Acetaminophen (Participant Controlled)CADD pumpParticipants will receive a CADD pump primed and programmed to deliver 650 mg liquid acetaminophen into a medication cup every 4 hours as needed (PRN).
Primary Outcome Measures
NameTimeMethod
Participant enrollment rateup to 12 months

The percentage of participants that enroll

Participant adherence to the study protocolup to 12 months

Percentage of participants that withdraw from treatment group, i.e. switch from patient controlled liquid group to the nurse-administered pill control group

Nurse QuestionnaireStudy day 0, 1, 2 and 3

Nurse ranking of patient controlled liquid oral acetaminophen vs. nurse-administered pill acetaminophen. (Mean score, Total Scale of 0-10: 0: much worse; 5:same; 10: much better)

Secondary Outcome Measures
NameTimeMethod
Mean daily acetaminophen consumption12 months

Mean daily acetaminophen consumption in milligrams collected using the electronic medical record

Mean Pain score12 months

Participants will be asked via Pain Diary to rate their pain using numeric pain scores from 0 to 10, 0 as no pain, 10 is the worst possible.

Mean time to medication delivery12 months

Medication delivery: Mean time in minutes from the time when pain medication requested by the participant to the time pain medication is delivered

Trial Locations

Locations (1)

Yale New Haven Hospital at St. Raphael's Campus

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath